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Abstract 
Hypertension, which is associated with an imbalanced autonomic nervous system, 
is becoming an increasing problem in the US and worldwide, and new therapies are 
needed, since not all patients respond to current medications. Vagus nerve stimulation 
(VNS), which aims to restore autonomic balance, has emerged as a promising new 
treatment for this disease. In our lab, we conducted an experimental study aimed at 
assessing the safety and efficacy of chronic, continuously cyclic VNS to attenuate the 
development of hypertension in spontaneously hypertensive rats. Hypertension was 
induced via a high salt diet and rats were randomized into two groups: Sham Control 
(n=6) and VNS Treatment (n=6).  In vivo blood pressure and electrocardiogram (ECG) 
were monitored continuously by an implantable telemetry system. We developed and 
validated methods to calculate time and frequency domain metrics for heart rate 
variability and blood pressure variability. Additionally, the sequence method in the time 
domain was employed to measure baroreflex sensitivity. Artifacts and ectopic beats can 
cause errors in the analysis of these metrics, so we also developed and validated robust 
pre-processing methods to edit ECG and pressure data in order to acquire clean signals.   
Results show that hypertension leads to decreased heart rate variability, decreased 
baroreflex sensitivity, and increased blood pressure variability, all of which are indicative 
of pathophysiological effects of hypertension. VNS may preserve heart rate variability 
blood pressure variability and baroreflex sensitivity at certain frequencies. 
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CHAPTER 1: INTRODUCTION 
 Overview of Hypertension 
Hypertension, or abnormally elevated arterial blood pressure, can be classified as 
either primary or secondary.  Primary, or essential hypertension is high arterial blood 
pressure that has no identifiable root cause (idiopathic), and it is this type that afflicts 
95% of patients diagnosed with hypertension [1].  Secondary hypertension refers to high 
arterial blood pressure with a clearly identifiable cause such as kidney disease or 
hyperthyroidism. This paper is concerned with primary hypertension, and any future 
mention of hypertension is referring to this type.  
Primary hypertension afflicts 75 million Americans and almost 1 billion people 
worldwide, and greatly increases the risk for heart disease and stroke, the first and third 
leading causes of death in the US, respectively [1], [2]. Current guideline-directed 
treatments call for a regimen of antihypertensive medications along with dietary and 
lifestyle changes; however, not all patients comply and/or respond to these treatments 
[3],[4]. Treatement resistant hypertension, defined as peripheral arterial blood pressure 
that remains elevated despite concurrent use of three antihypertensive agents of different 
classes, is becoming more prevelant and an increasing problem. It is estimated that 20-
30% of all “hypertensives” have the treatment resistant type [5]. There is a clear unmet 
need for new and effective alternative treatments for these patients who do not respond to 
drugs, hence the recent focus on device-based approaches, such as VNS. 
   2 
Despite decades of basic and clinical research, primary hypertension still has no 
firmly established etiology, although some of its pathophysiology has been identified.  
Strong evidence has shown that hypertension is associated with autonomic imbalance 
characterized by sympathetic hyperactivation and parasympathetic withdrawal [6]–[8]. 
Vagus nerve stimulation, which aims to rebalance the autonomic nervous system, has 
emerged as a promising solution to combat the autonomic imbalance associated with the 
hypertensive state.  
Physiology Review 
Control of Blood Pressure  
To understand how an imbalanced autonomic nervous system (ANS) plays a role 
in hypertension (HTN), it is important to review how blood pressure (BP) physiology and 
control mechanisms operate under normal conditions. At any moment, the pressure 
gradient across the vasculature is equal to the central venous pressure (CVP) subtracted 
from the mean arterial pressure (MAP). This gradient is equal to the product of cardiac 
output (CO) and total peripheral resistance (TPR). Since CVP is at or near 0 mmHg, the 
equation becomes:  
 MAP = CO x TPR   (1.1) 
TPR refers to the resistance to blood flow realized by all the systemic vasculature. This 
resistance is usually dependent on vessel diameter, but can also be affected by blood 
viscosity and vessel length.  CO is a volumetric flow rate and represents the volume per 
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time pumped by the heart, usually expressed in L/min.  Since CO is equal to the product 
of stroke volume (SV) and heart rate (HR), equation 1.1 can be rewritten:  
MAP = SV x HR x TPR  (1.2) 
Each of the three variables on the right of this equation is influenced by complex 
physiological parameters and the variables may also interact with one another. The 
overall system is summarized in Figure 1.1. The ANS, made up of the sympathetic 
nervous system (SNS) and parasympathetic nervous system (PNS), can modify virtually 
all the variables in Figure 1.1, either directly via post-synaptic effects of 
neurotransmitters, or indirectly by activating hormonal systems. For example, acute 
increases in SNS activity will affect the heart and vasculature almost immediately, 
resulting in increased CO and TPR, and thus BP. The SNS also acts on a longer time 
scale, to promote renin release in the kidney, which increases sodium and water retention 
and raises blood volume [9].  In summary, increased SNS activity tends to promote 
higher BP, both acutely and chronically, and PNS activity promotes the reverse.  
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  Figure 1.1: Factors that influence blood pressure (Reproduced with permission from [9]). 
Negative Feedback Systems in Blood Pressure  
Many different systems “sense” BP perturbations that deviate from a set point and 
react in a way that tends to return BP to that same set point. This phenomenon is often 
referred to as BP homeostasis. One of the most prominent negative feedback loops 
involved in BP homeostasis is the baroreflex. Arterial baroreceptors located in the aorta 
and carotid sinuses increase their firing rate in response to stretching of vessel walls. An 
increase in MAP leads to an increased firing rate of the receptors, and a decrease in MAP 
leads to a decreased firing rate. These receptors then transduce and relay this pressure 
information, in the form of afferently propogating action potentials, to the medullary 
brain stem where it is processed and neural responses are activated [1]. This afferent 
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portion of the baroreflex is displayed on the left side of Figure 1.2, and the efferent 
portion of the baroreflex is displayed on the right side.  
The efferent portion consists of the sympathetic branch and the parasympathetic 
branch. The sympathetic branch innervates the sinoatrial (SA) node and atrioventricular 
(AV) node in a way that increases HR as well as conduction velocity. Sympathetic nerves 
can also significantly alter contractility (force production) of the heart and innervate 
blood vessels, leading to increased TPR. All of these changes work together to raise BP 
(see equation 1.2). The parasympathetic branch of the baroreflex consists of the right and 
left vagus nerves. These nerves innervate the heart at the SA and AV nodes to reduce HR 
and conduction velocity. Parasympathetic nerves also sparsely innervate the periphery of 
the heart, so can slightly reduce contractility. Vagal efferents do not predominantly 
innervate the vasculature so do not modify TPR [9]. The baroreflex acts by adjusting both 
the PNS and SNS simultaneously. If afferent discharge from baroreceptors is increased, 
signaling an increase in BP, the medullary control center will trigger a reflex response 
that activates parasympathetic efferent activity and inhibits sympathetic efferent activity, 
ultimately leading to a decrease in BP.  The reverse will occur if afferent discharge 
decreases. Note that this efferent system does not solely belong to the baroreflex – other 
inputs are involved such as the chemoreceptor reflex; essentially, it represents the most 
direct and immediate method by which the ANS controls the cardiovascular system [1], 
[10].  
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Figure 1.2: Baroreflex Arc. Left side displays receptors and afferent portion, right side displays 
efferent portion. Reproduced with permission from [1]. 
 
There are important time delay differences between the SNS and PNS responses 
in this efferent system.  It has been shown that vagal efferent nerves are able to respond 
to pressure changes almost immediately and can affect HR on a beat-to-beat basis, 
whereas the SNS is characterized by a time delay and longer lasting effects [10], [11]. 
Therefore, the PNS has control of HR at higher frequencies, the implications of which 
will be discussed in subsequent sections. One biochemical explanation for the differing 
delay times for PNS and SNS effects on HR is that the SNS requires the use of the second 
messenger cAMP system to change heart dynamics whereas the PNS does not [12].  
The baroreceptor reflex is considered “neural” control of BP, as is the 
chemoreceptor reflex, which has a similar negative feedback loop. Humoral control of 
HR and BP through circulating hormones also occurs and has been shown to be slower-
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acting than neural control [10], [11]. Humoral factors which affect BP include circulating 
catecholamines, the renin-angiotensin-aldosterone system (RAAS), atrial natriuretic 
peptide, anti-diuretic hormone (vasopressin), and others [1]. Local mechanisms, such as 
the myogenic vascular response and the endothelial nitric oxide system are able to 
regulate BP on a local level by altering vessel caliber, and can operate independently of 
neurohormonal influences [9]. The control of BP involves many different control loops 
operating with different time constants. It’s important to note that many of the control 
loops are interdependent and constantly interacting. For example, an activation of the 
baroreflex may cause autonomic innervation of the heart through vagal or sympathetic 
efferent nerves, generating a fast response, but this same activation may also play a role 
in longer-term hormonal control mechanisms.  
Assessing ANS Through Cardiovascular Variability  
Overview 
In daily life, external perturbations initiate BP fluctuations, and neural and 
hormonal control mechanisms respond to oppose these perturbations to bring BP back to 
a reference “set point.”  Therefore, rather than being random noise, variability in HR and 
BP can reflect the health and performance of cardiovascular homeostatic mechanisms. 
Almost all of the mechanisms to control BP discussed in the previous section are affected 
by cardiovascular diseases, including HTN. [13].   
Heart rate variability (HRV), or variation in the time between heartbeats, has 
become a popular clinical and investigational tool over the past 30 years [14]. In HRV 
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analysis, it is generally the changes in RR-interval that are analyzed rather than changes 
in HR. The RR interval is constantly changing on a beat-to-beat basis, but also varies 
over larger time intervals from hours to days.  It has been shown repeatedly that the ANS 
plays a significant role in the production and modulation of these oscillations, and that 
HR measures can give insight into the underlying pathophysiology of the ANS under 
many different maladies; additionally, certain HRV measures offer significant prognostic 
value [8], [15]–[18].  Reduced HRV has been linked to increased mortality in both 
humans and animals and has been shown to be prevalent in hypertensive patients [6], 
[19]. 
Blood pressure variability (BPV) is less established as a marker of autonomic 
function, but is closely linked to HRV, and the simultaneous analysis of HRV, BPV and 
the baroreflex that links BP to HR may provide deeper insights into underlying 
pathophysiology. Compared to HRV, BPV has less standardized methods for 
measurement, although studies typically define BPV as variation occurring in the 
sequences of systolic, diastolic, or mean arterial pressures calculated at discrete time 
points. BPV does not refer to differences between systolic and diastolic pressures, which 
is termed pulse pressure. In the case of VNS, it makes sense to measure oscillations in 
both HR and BP, since the ANS regulates many of these oscillations, and VNS has been 
shown to directly affect the ANS [20]. 
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Measurement Techniques  
There are many established methods for measuring HRV (and less so BPV), 
which can be categorized into two main groups: time domain techniques and frequency 
domain techniques. In frequency domain analysis, either fast Fourier transformation or 
auto-regression techniques are used to decompose the signal into its frequency 
components. Historically, fluctuations in RR interval and BP have been categorized into 
four different “types,” or frequency bands: high frequency (HF), low frequency (LF), 
very low frequency (VLF) and ultra low frequency (ULF) oscillations. Frequency domain 
parameters are calculated as the area under the curve of the power spectral density (PSD) 
in the frequency range of interest. These frequency ranges can differ between studies, but 
common values for humans are displayed in Table 1.1. A representative power spectrum 
of a 24-hour recording of RR intervals in a human displaying the four frequency bands is 
shown in Figure 1.3. Researchers have attempted to correlate each of these frequency 
bands in Figure 1.3 to various physiological mechanisms; a detailed discussion of these 
correlations is presented in Appendix A.  
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Figure 1.3: Power spectral density showing frequency bins. Reproduced from [21] 
 
 
Table 1.1: Frequency bands as defined in humans from [21]  
Frequency Band Frequency in Humans Period of Oscillation in 
Humans 
High Frequency (HF) 0.15-.4 Hz 2.5 - 6 seconds 
Low Frequency (LF) 0.04-0.15 Hz 6-25 seconds 
Very Low Frequency (VLF) 0.0033 -0.04 Hz 25 seconds to 5 minutes 
Ultra Low Frequency (ULF) Less than 0.0033 Hz  Greater than 5 minutes 
 
In time domain analysis, intervals between adjacent “normal” QRS complexes are 
calculated to acquire a recording of NN (Normal-to-Normal) intervals (as opposed to RR-
intervals, which retain intervals due to ectopic beats) [14]. Note that noise and arrhythmic 
episodes can greatly influence HRV measurements and need to be removed carefully 
(editing of data is discussed in the methods section).   
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SDNN is the standard deviation of all NN-intervals over a certain time period; 
usually a 5 minute or 24 hour recording is used, although other time lengths are permitted 
and have been used in studies [17].  However, if different time lengths are used, caution 
must be taken in making any cross-study comparisons. SDANN is the standard deviation 
of the average of NN intervals. To calculate SDANN, compute the average NN interval 
over a 5-minute segment, and then take the standard deviation of these averages 
Essentially, it is akin to applying a moving average filter to the NN intervals and then 
taking a standard deviation. 
SDANN =  std(µ1, µ2, … µN)    (1.3) 
SDANN effectively “filters” out oscillations with periods shorter than 5 minutes. This 
metric is less subject to editing errors than SDNN because the averaging over 5 minutes 
minimizes effects due to unedited artifacts, missed beats, and arrhythmias [21]. ASDNN 
is the average of the 5-minute standard deviations of NN intervals. ASDNN is calculated 
by taking the standard deviation of 5-minute NN interval segments, and then averaging 
these standard deviations. ASDNN reflects oscillations with periods less than 5 minutes 
in length; it removes long-term effects such as those due to circadian rhythms and 
hormonal systems. 
ASDNN = mean(std1, std2… stdN)   (1.4) 
 
RMSSD is the root mean square of successive differences. This calculation 
consists of calculating successive differences between NN intervals, squaring each 
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difference, adding these squared differences together, and then taking the square root of 
the sum.  It is meant to gauge the amplitude of high frequency oscillations. 
RMSSD = sqrt(mean(∆D12, ∆ D22… ∆ Dn2)  (1.5) 
A visual representation of these time domain parameters based on data acquired in this 
study is presented in the results section, “Qualitative Examination of Data.” 
Vagus Nerve Stimulation  
In theory, there are two ways to combat the imbalanced ANS associated with 
HTN.  “Beta-blockers” have long been established as a treatment for HTN with the goal 
of reducing the functional effects (adrenergic receptor activation) of sympathetic activity; 
however, this treatment does not directly impact diminished cardiac vagal tone that 
accompanies autonomic imbalance [22]. VNS is original in its ability to augment vagal 
tone.  
The mechanisms underlying the effects of chronic VNS are not fully understood. 
Acutely, stimulation of the efferent fibers of the vagus nerve bundle may cause 
chronotropic (reduced HR), dromotropic (reduced AV conduction velocity), and 
inotropic (reduced contractility) effects on the heart; however, these acute effects are 
probably not the primary cause of long term benefits of VNS [20], [23]. Kakinuma et al 
showed that efferent VNS was able to produce cardioprotective effects via acetylcholine 
release in the heart independent of HR-decreasing effects [24]. 
Ostensibly, chronic VNS results in long-term vagal up-regulation on a broad 
level, and therefore improved autonomic balance [23]. This vagal up-regulation may 
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result in a concomitant reduction in sympathetic activity, owing to the two systems’ 
antagonistic effects on each other [22]. For example, electrical stimulation of the cardiac 
parasympathetic nerves is reported to attenuate norepinephrine (a SNS neurotransmitter) 
spillover in the left ventricle [25]. Zhang et al showed that VNS reduced plasma 
angiotensin II levels in dogs with heart failure, and Mancia et al demonstrated that 
activation of vagal efferents can decrease the release of renin [23], [26]. Mancia’s study 
provides further evidence that VNS reduces SNS activity, but also indicates that VNS 
therapeutic effects may partially result from an inhibited RAAS.  Lastly, VNS has anti-
inflammatory and antioxidant effects. Zhang et al also showed in their study of VNS-
treated dogs that plasma-C reactive protein, a marker of inflammation, was significantly 
reduced.  In summary, VNS has been shown to have complex and diverse therapeutic 
effects that may manifest through many different pathways.  
Goals of the Thesis 
Vagus nerve stimulation has emerged as a promising new treatment for essential 
HTN and it is the goal of our lab to evaluate its efficacy in treating HTN and HTN-
induced heart disease. This thesis aims to contribute to this overall goal through the 
analysis of ECG and pressure data derived from HTN and VNS-treated HTN rats. Early 
on in the research, we discovered a clear need in our lab for new approaches to evaluate 
autonomic and physiological function using solely ECG and pressure data. Therefore, a 
primary goal is to investigate and implement in MATLAB recent approaches that use 
ECG and pressure data to assess cardiovascular health. While other metrics were 
   14 
investigated, this thesis will exclusively focus on HRV, BPV and baroreflex sensitivity. 
We also discovered that extensive pre-processing of data is required in order to 
accurately calculate HRV, BPV, and baroreflex sensitivity; these metrics are easily 
corrupted by artifacts of both physiological and technical origin. Thus, another product of 
this thesis is a development of pre-processing methods in MATLAB aimed at acquiring 
clean data sets, Lastly, the completed MATLAB software will be applied to data 
extracted from both hypertensive rats with VNS treatment and rats without treatment, to 
better elucidate underlying physiological effects of vagus nerve stimulation.  
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CHAPTER 2: METHODS 
Experimental Protocol 
Dahl Salt Sensitive (DS) male rats (29-35 days old, Charles River Laboratories, 
Wilmington, MA) were used in this study. These rats offer a genetic model of HTN that 
develops early and is maintained by a high salt diet [27]. After 4 weeks of 8% NaCl high 
salt diet (S100001, Research Diets, Inc., NJ, USA), vagus nerve stimulators (Demipulse, 
Model 103, Cyberonics, Inc, Houston, TX  USA) and telemetry systems (HD-S11 Data 
Sciences International, St Paul, MN  USA) were implanted, and rats were randomly 
divided into two groups: HTN-VNS (n = 6, with functional VNS stimulator implants), 
and HTN-Sham (n = 6, with nonfunctional VNS stimulator implants of the same mass). 
Bipolar cuff platinum-iridium electrodes were placed around the right cervical vagus 
nerve and common carotid artery bundle, and the pulse generator (8 cc, 14 g) was 
implanted subcutaneously and positioned in a subcutaneous pocket on the back of each 
rat. Parameters of the intermittent VNS are displayed in Figure 2.1 along with a timeline 
of the study. These parameters were determined based on previous studies performed in 
the lab by Elizabeth Annoni. A pressure-sensing catheter was implanted into the 
descending aorta via the left femoral artery, and two ECG leads were fixed subdermally 
onto the chest muscle. Electrograms and arterial pressure were recorded at 500 Hz. Rats 
were conscious and freely moving in their home cages for the duration of the in vivo 
portion of the study.  
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Figure 2.1: Timeline of experiment. 
 
Data “Pre-Processing” 
After rat death, we analyzed approximately 12 hours of raw ECG and BP data as 
follows: 4 hours from week 6 (W6), 4 hours from week 9 (W9), and 4 hours from day 
before death (DBD). Some rats did not live until W9, so W9 was omitted for these rats 
(see Figure 3.1).  The four-hour segments were taken from 10:00 PM- 2:00 AM, during 
“wake time” when rats are most active, and sympathetic activity is highest. To enable a 
more robust analysis, we extracted data from Ponemah software as ASCII (American 
Standard Code for Information Interchange) files, then converted and uploaded them into 
MATLAB. In previous studies, most analysis had been completed in Ponemah or other 
commercial software so the use of MATLAB to quantify HRV, BPV and baroreflex 
sensitivity was a novel technique used in our lab, with all code written de novo. After the 
data was uploaded to MATLAB, several filters were applied to remove noisy segments. 
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Peltola gives a detailed explanation on the editing of RR interval data in [28], and the 
procedures used in this study are in line with instructions presented there. We adapted 
other editing and analysis procedures from the Task Force of the European Society of 
Cardiology’s recommendations on HRV, as well as Bernston et al [10], [17].In addition, 
we reviewed and incorporated techniques used in rat studies in which HRV and BPV 
analysis was performed [11], [29]–[33]. 
The first filter removed saturated signals of pressure and ECG, meaning extreme 
high-valued, “non-physiological” noise. The filter then spliced together the segments on 
either side of the removed saturated portions as seen in Figure 2.2.  
 
Figure 2.2: Removal of saturated segments of data, with an example of a splice point 
displayed.  
 
Splicing introduces a point in the data that can lead to incorrect calculation of RR 
intervals, so minimizing the number of splices is ideal. To minimize splice points, when 
Splice	
Point		
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two saturated segments existed in close proximity to each other, the filter algorithm 
removed both saturated segments, as well as any “clean” data in between the two 
segments. Therefore, some clean data was sacrificed. The splice points that remain were 
dealt with through subsequent editing techniques.  For some data traces, removal of 
saturation resulted in a shortening of the data set as demonstrated in Figure 2.3. The 
shortest data set after saturation removal was 168 minutes, and to ensure uniformity of 
length, all other data sets were cut to 168 minutes.  
 
Figure 2.3: In this data file, removal of saturation points resulted in a significant shortening of 
the data trace.  
 
After the initial filtering to remove saturation, systolic blood pressures (SBP), 
diastolic blood pressures (DBP) and QRS complexes were calculated using a peak-
finding function in MATLAB. RR intervals were initially calculated as the time 
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difference between two consecutive QRS complexes.  To identify the QRS complex, 
established methods such as the Pan-Tompkins algorithms and others were first used, but 
these proved unsatisfactory (many QRS Complexes were not identified accurately during 
stimulation and with other artifact effects) [34]. We therefore created a custom algorithm 
that identified the QRS complex based on peak size, and temporal proximity to the 
nearest systolic and diastolic peaks in the pressure trace (Figure 2.4). In this way, each 
QRS complex must have an associated systolic peak and diastolic peak. This algorithm 
proved accurate and was validated under a variety of conditions, including during 
stimulation and during ectopic beats. If examined closely, it can be seen in Figure 2.5 that 
the QRS peak is calculated correctly during stimulation, as depicted as the lighter colored 
triangles. 
 
Figure 2.4: Algorithm for detecting QRS complex based on temporal proximity to previous SBP 
peak and subsequent DBP peak.  
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Figure 2.5. The algorithm detected correct QRS complexes (seen as the lighter colored triangles) 
during vagus nerve stimulation periods.  
 
While this algorithm seemed to work well, it was abandoned after it was 
discovered that two of the rats had ECG traces in which QRS complexes were entirely 
indiscernible, even visually (Figure 2.6).  
 
Figure 2.6.  Some ECG traces had indiscernable QRS complexes.  
 
We therefore decided that HR information would have to be gleaned from the BP 
trace. Pulse interval (PI), the time difference between two consecutive systolic (or 
diastolic) peaks, was first used to replace RR interval calculated from ECG data. For 
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most of the data, this method worked well, but under certain situations led to incorrect 
calculations; for some of the data, there was a relatively wide range in which a systolic 
peak could be defined. Figure 2.7 displays how this phenomenon can lead to “short” and 
“long” PI’s being calculated. This small error in calculation appears as noise in the pulse 
interval trace (Figure 2.8).  Therefore, we took the derivative of the pressure and 
calculated peaks from this data trace in order to calculate pulse interval (PI), as seen in 
Figure 2.7. This method proved more accurate and corresponded well to RR interval 
(Figure 2.8).  
 
Figure 2.7. Some pressure traces had a wide systolic peak, which could lead to shorter or longer 
PI’s being calculated in certain cases. 
 
 
Short	PI	 Long	PI	
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Figure 2.8.  Methods for calculating intervbeat interval. In the second subplot, calculating pulse 
interval from systolic peaks leads to errors in calculation which cause noise. This noise is shaded 
a different color because originally it was removed with a filter.  
 
Since PI is used, both BP data and HR data are derived from the pressure trace, 
and the ECG trace becomes irrelevant.  After systolic peaks were calculated, an algorithm 
was employed to “match” every systolic peak with its subsequent derivative peak (the 
peak calculated on the pressure derivative trace). This matching algorithm is necessary to 
ensure a 1:1 correspondence between systolic peak and derivative peak, and thus pulse 
interval. This matching is mainly important for baroreflex sensitivity analysis, but is also 
an initial filter for arrhythmic events in which 2 systolic peaks occur in a row with only 1 
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corresponding RR interval.  The matching protocol is depicted in Figure 2.9: SBPi  is 
matched with PIi+1,  giving a delay of 1: this information is important for baroreflex 
sensitivity analysis, which is discussed in a later section.  
 
Figure 2.9: Matching protocol between SBP and PI ensures a 1:1 correspondence. Time vectors 
were recorded to store the timings SBP and PI samples. The time of SBPi  is straightforward; it’s 
recorded as the time at which the peak occurs. The “time stamp” for PI is taken as the time of the 
first peak used in the calculation.   
 
After SBP and PI signals were acquired and “matched,” they had to be put 
through additional filters to remove arrhythmias and remaining non-physiological noise, 
which can significantly influence BPV and HRV calculations [28]. In addition, the 
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“splice” points discussed earlier led to the calculation of incorrect systolic peaks in some 
cases. These next filtering steps required several iterations. In Aubert et al, two filters 
were used for rat RR interval data: a percentage filter, that removes any value that 
deflects by more than 20% of previous one and replaces this value by the mean value of 
the five preceding and five following values, and a second filter that removes and 
replaces deflections that differ by more than three standard deviations from the overall 
mean value. Both of these filters were experimented with, but proved unsatisfactory for 
data sets in this experiment – they tended to unnecessarily remove data that was not due 
to ectopic beats. Instead, a filter similar to the “percentage filter” was used; if a value 
differed by more than	± ‘X’ mmHg, it was removed and replaced via linear interpolation. 
Interpolation, rather than deletion, is the recommended method of several sources [10], 
[28]. The value ‘X’ was arrived at by visually examining the data set and choosing the 
value of X that appears to best remove ectopic artifacts; if it is too high, than data is 
unnecessarily edited, if it is too low, than artifacts can remain. Thus, the value ‘X” was 
“customized” for each rat data set. ‘X’ was initially set at 20 mmHg and this value 
worked well for the majority of data sets, but for a few of them, had to be lowered to 
ensure all artifacts were removed. While this visual customization method may seem 
crude, there is a basis for it in the literature. In “Role of Editing,” Peltola explains: “many 
experts believe that manual editing with visual verification of the R-R intervals and a 
careful choice of the appropriate editing method is a more reliable method and can never 
be fully replaced by the current automatic correction systems.” Thus, filtering methods 
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used here were in line with HRV expert’s current recommendations.  Results of the filter 
described above are displayed in Figure 2.10.  
 
Figure 2.10: Removal of ectopic beats and replacement via linear interpolation. 
Data “Post Processing” 
Once the SBP and PI signals are calculated with noise removed, data “post 
processing” can take place, in which time and frequency domain parameters for HRV and 
BPV are calculated, as well as baroreflex sensitivity (BRS) using the sequence method. 
MATLAB code was created to calculate the time domain parameters discussed in the 
introduction: SDNN, SDANN, ASDNN, and RMSSD. Time domain calculations were 
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straightforward and are not elaborated upon. There are several different methods to 
calculate frequency domain parameters, which are described next. 
Frequency Domain Methods  
 For frequency domain methods, the PI and SBP sequences first need to be 
resampled, since HR and SBP values occur at uneven sampling intervals. Following a 
technique described in Aubert et al, “Analysis of HRV in unrestrained rats: Validation of 
Method and Results, ” the signals were first de-trended and then resampled using spline 
interpolation at 10 Hz; this frequency was chosen as an adequate resampling frequency to 
ensure HR’s up to 600 beats per minute (BPM) could be captured without any loss 
(aliasing) of information (600 BPM is equivalent to a heart period of 100 ms). In this 
way, the discrete point processes are approximated by a continuous function sampled at 
10 Hz. 
The power spectral density was calculated using the fast Fourier transform (FFT) 
in MATLAB in two distinct ways. The first technique was fairly straightforward; the 
power spectrum was calculated for the entire 168-minute data set, and ULF, VLF, LF, 
and HF power were calculated as the area under the power spectrum in the corresponding 
frequency band (Figure 2.11). Authors have used several different ranges for the 
frequency bands in rats, which are displayed in Table 2.1. 
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Figure 2.11. Power spectrum of entire data set in rats. The peak in the HF range at around 1.4 
Hz corresponds to the respiratory rate in rats of 85 breaths/min [35] 
 
 
Table 2.1: Frequency ranges used in rats 
Parameter Cerutti,  
Gustin et al 
Cerutti, 
Barres, et al 
Henze et al  Stauss Aubert et al Ning et al  
HF Power 
Range (Hz) 
0.75 – 3.85 0.76 – 5  1-3  1-4  0.78-2.5  0.78- 2.5 
LF Power 
Range (Hz) 
0.27 – 0.74 0.27 – 0.74 0.05-1  0.2 -0.6  0.19-.74  0.195- 0.74 
VLF Power 
Range (Hz) 
0.015-.255  0.0195 – 
0.25 
N/A 0.02- 0.2  N/A N/A 
ULF Power  
Range (Hz) 
No study found in which ULF power was measured in rats.   
 
The second technique was performed according to a procedure used by Cerutti et 
al in their studies of rats, which aims to acquire more accurate calculations for HF and LF 
power [30], [31]. For each 168 minute recording, the data was divided into segments of 
395 segments of n=512 points overlapping by one-half. For each segment, a PSD was 
calculated, and a corresponding HF and LF power were calculated (these data segments 
HF	LF	VLF	ULF	
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were too short for VLF and ULF power).  Outliers were then removed from the 395 
values of HF and LF power and an average value was computed.   
Several problems arose with frequency domain methods, which are presented in 
the discussion section. Based on these problems and some unanswered questions, we 
determined that further investigation is needed before frequency domain parameters, 
other than HF power, can be used to reliably gain information about the ANS for the data 
in our study. Therefore, only HF power computed using the second technique is the only 
frequency domain parameter presented in the results. 
Baroreflex Sensitivity by the Sequence Method 
As with HRV and BPV, both frequency domain and time domain methods exist 
for measuring the baroreflex. The “Sequence Method,” developed in 1985 by Berterini, is 
the most common one used in the time domain, and the parameter “measured” is termed 
Baroreflex Sensitivity (BRS) [36].  BRS can be measured in other ways than the 
sequence method, but BRS is usually defined as the change in inter-beat interval per unit 
change in BP [37]. In its early days, BRS was measured by triggering a change in BP by 
giving patients an intravascular injection of a vasoconstrictive or vasodilative agent and 
observing changes in HR [38]. In recent years, researchers have turned to measuring BRS 
noninvasively, by observing the “spontaneous baroreflex,” meaning sequences that occur 
due to fluctuations in BP that occur spontaneously throughout a normal day [38]. The 
sequence method involves identifying sequences of a minimum number of consecutive 
beats characterized by either a progressive rise in SBP and lengthening of PI, or a 
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progressive decrease in SBP and shortening of PI. Examples of baroreflex sequences are 
displayed in Figure 2.12.  Each sequence has an associated regression line and gain (slope 
of regression line). BRS is calculated as the average value of the gains for all sequences.  
 
Figure 2.12: Baroreflex sequences from [38]. 
 
There are threshold criteria associated with the sequence method which are 
detailed in [37] and [38].  Most studies use a minimum coefficient of correlation (R2 
value), which refers to the linear fit of the regression line seen in Figure 2.12. 
Additionally, a minimum number of points in a sequence are required; usually, three or 
four beats. Lastly, a minimum rise or drop in pressure and sometimes RR interval can be 
required.  MATLAB code was developed to carry out the sequence method. As 
mentioned, systolic peaks were matched with subsequent pulse intervals calculated from 
derivative peaks with a delay of 1.  
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After initial analysis, it was determined that the breathing frequency had a 
significant effect on the types of sequences observed. In Figure 2.13 it can be seen that 
respiratory oscillations are superimposed over lower frequency movements and that 
coherency between SBP and PI likely occurs at more than one frequency. At around 850 
ms, a large decrease in SBP and a corresponding decrease in PI occur, indicating that the 
baroreflex is acting at this lower frequency. However, the sequence method algorithm 
does not detect this event because it is not a constant decrease in both variables; instead 
the decrease is disrupted by respiratory oscillations. To ensure the capture of lower 
frequency sequences, both the SBP and PI signals were low pass filtered to remove 
respiratory oscillations. The resulting signal is represented by the dotted line in Figure 
2.13.  The same number of data points and sampling interval were retained in the filtered 
data.  
 
Figure 2.13: Dotted line represents low pass filtered data.  
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Figure 2.14 shows unfiltered SBP and PI samples and Figure 2.15 shows filtered 
SBP and PI signals, both after the application of the sequence method. The sequences 
depicted in Figure 2.14 are representative of coherence between SBP and PI at the 
respiratory frequency, while the sequences depicted in Figure 2.15 represent coherence 
over a lower frequency.  
 
Figure 2.14: Sequence Method applied to unfiltered data 
 
 
Figure 2.15: Sequence Method applied to filtered data. 
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Statistical Analysis 
The paired t-Test carried out in Microsoft Excel was used to compare W6 results 
to DBD. In addition, W6 to W9 and W9 to DBD were also compared using the paired t-
test. In addition, the changes in parameters from W6 to DBD were compared between 
Sham and VNS using a two-sample unequal variance t-Test. For example, Sham could 
have an average increase in a certain parameter, and VNS could have an average increase 
in the same parameter; it is these increases (or decreases) that are being compared. 
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CHAPTER 3: RESULTS 
Survival Data  
As a group, VNS Treatment rats survived longer than Sham Control rats after the 
start of VNS at W6 (P <0.05). The average lifespan after W6 for Sham was 48% shorter: 
20.2 days for Sham vs 38.8 days for VNS. Survival data for each rat is shown below. 
Note that only 3 Sham and 5 VNS rats were available for W9 analysis since some rats 
died before W9. 
 
Figure 3.1: Survival Data - VNS outlived Sham. 
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Mean Heart Rate and Blood Pressure 
Increases in SBP are seen in both Sham and VNS rats from W6 to DBD with 
statistical significance. No statistically significant trend is seen in mean HR for Sham nor 
VNS, although qualitatively mean prevailing HR appears to slightly decline in VNS rats 
over time.  
 
 
Figure 3.2: Mean HR and BP  
 
Heart Rate Variability and Blood Pressure Variability 
Methods were developed to measure HRV and BPV in both the time and 
frequency domain in MATLAB. However, later in the research, several issues arose with 
frequency domain methods that remain unresolved; these issues are presented in the 
discussion. Therefore, HF power is the only frequency domain parameter presented here. 
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Qualitative Examination of Data 
Representative samples of data are shown in Figures 3.3 and 3.4 that provide 
visual aid in understanding time domain parameters.  
 
Figure 3.3: The dotted line above is the result of low pass filtering pulse interval at 0.0033 Hz 
 
In Figure 3.3 above, a low pass filter with a cutoff frequency of 0.0033 Hz was 
applied to give the dotted line seen. Since SDANN averages every 5 minutes, it aims to 
track these long-term oscillations depicted by the dotted line: 1 divided by 300 seconds 
(or 5 minutes) is equal to 0.0033 Hz. ASDNN only measures oscillations with periods 
below 5 minutes: it quantifies oscillations that would remain if the dotted line were 
removed from the data above. SDNN quantifies oscillations across all frequencies, and is 
simply a standard deviation of the entire data set.  
Figure 3.4 is a zoomed-in version of Figure 3.3. Respiratory oscillations are 
superimposed over lower frequency oscillations in this figure. RMSSD and HF power 
quantify these respiratory oscillations. HF Power was calculated using the 2nd technique 
presented in the methods. The frequency range for HF power was chosen as 1-4 Hz, 
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which is the value cited by Stauss [13].  The respiratory rate (as approximated by the 
location of the HF peak) of all rats in the study was above 1 Hz, so this range seems 
acceptable. 
 
Figure 3.4: Only respiratory oscillations remain after high-pass filtering 
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Heart Rate Variability Plots 
For HRV, SDNN, SDANN, and ASDNN all decreased for Sham rats, with 
statistical significance (P<0.05) only seen in ASDNN (Figure 3.5). No statistical 
significance is observed for any of the parameters in VNS rats, although qualitatively 
VNS rats appear to decrease in HRV from W6 to W9, and possibly regain some of this 
variability (as measured by SDNN and SDANN) from W9 to DBD.  
  
 
 Figure 3.5: Time domain measures for overall HRV 
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HF power results appear to mirror results seen in RMSSD (Figure 3.6); this agrees 
with previous studies that have correlated RMSSD with HF power [21], and makes 
intuitive sense since both parameters are measuring high frequency respiratory 
oscillations. RMSSD and HF power from W6 to DBD decrease in Sham rats (P=0.021, P 
= 0.032, respectively). Qualitatively these same parameters in VNS rats decrease slightly 
from W6 to W9, and from W9 to DBD appear to increase slightly; however, these trends 
don’t attain statistical significance. 
   
Figure 3.6: HRV at high frequencies 
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Blood Pressure Variability Plots 
For BPV calculations, overall variability measured by SDNN increases from W6 
to DBD in both Sham and VNS rats (no statistical significance). Both groups also 
increase in ASDNN (statistical significance was only seen for VNS rats, P = 0.012).  
SDANN appears to change very little from W6 to DBD.  
  
 
Figure 3.7: Time domain measures for overall BPV 
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Similar to HRV results, RMSSD and HF power mirrored each other for BPV. 
Both parameters increased from W6 to DBD in both Sham and VNS rats, indicating that 
high frequency fluctuations in BP are increasing. High frequency fluctuations in BP are 
mechanically induced through respiration.  
  
Figure 3.8: BPV at high frequencies 
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Baroreflex Sensitivity 
Representative sequences obtained using the sequence method are displayed in 
the Methods section.  As discussed there, the sequence method was applied to both raw 
data as well as filtered data in which the respiratory oscillations were removed. For the 
raw data, the following threshold criteria were used: minimum sequence count of 4, 
minimum required increase/decrease in pressure of 1 mmHg, and a minimum R2 value of 
0.9.  These values are fairly standard and agree with values cited in the “EuroBaVar” 
study by Laude et al, which compares various methods for calculating baroreflex 
sensitivity [39].  
The sequence method was also applied to filtered data. The filtering of data prior 
to application of the sequence method is a new technique, and no threshold criteria for 
this method have been established. Therefore, threshold criteria were manually tuned. If 
the minimum sequence count or required pressure change were too low, the algorithm 
would pick up sequences that did not look like baroreflex sequences. Therefore, threshold 
criteria were raised from the values used for unfiltered (raw) data in order to be more 
restrictive.  This alteration of threshold criteria occurred based on a visual examination of 
which threshold values appeared to accurately capture baroreflex sequences. The 
following parameters worked well:  minimum sequence count of 16, a minimum required 
increase/decrease in pressure of 5 mmHg, and a minimum R2 value of 0.9. Other 
threshold criteria near these values were experiemented with and gave similar results 
(results did not appear to be dependent on threshold criteria).  
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Figure 3.9: Baroreflex Sensitivity (BRS) unfiltered data: Minimum Sequence Count = 4, 
Minimum Required Increase/Decrease in Pressure = 1 mmHG, Minimum R2  =0.9 
 
Figure 3.10: Baroreflex Sensitivity (BRS), low pass filtered data to remove breathing frequency. 
Minimum Sequence Count = 16, Minimum Required Increase/Decrease in Pressure = 5 mmHg, 
Minimum R2 =0.9 
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CHAPTER 4: DISCUSSION 
Survival Data 
Survival data shows that VNS rats outlived Sham rats (P<0.05). This implies that 
VNS was able to significantly alter the physiology of the rats. 
Average BP and HR 
Both Sham and VNS rats experienced statistically significant increases in mean 
SBP during the period from 10PM – 2AM. It is somewhat surprising that an attenuation 
of BP did not occur in VNS relative to Sham. One possible explanation relates to data 
from a previous study in our lab demonstrating that VNS induces greater modulation of 
MAP during the daytime, when the nocturnal rats are less active [20]. Data in our current 
study was collected at night, when rats are awake and sympathetic activity dominates. 
During this time, VNS may be less able to produce an attenuation in BP.  A second 
explanation is that VNS may exert therapeutic effects independently of BP changes, or 
that BP changes take longer to occur than other therapeutic effects.  Zhang et al. showed 
that in dogs, therapeutic effects of VNS resulted without any change in systemic BP [23]. 
Thus, similarities in BP for Sham and VNS rats are due in part to day/night activity, but 
in addition, VNS might produce certain therapeutic effects more immediately by down-
regulating the SNS, but large changes in BP can take longer to achieve. 
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There were no statistically significant differences in mean HR from W6 to DBD 
for either group, although VNS rats did display a slight decrease in HR, which may 
reflect the acute bradycardic effect of VNS. A significant acute bradycardic effect was 
observed in only 1 of the VNS rats.  
Although analysis of survival data implies that physiological changes are 
occurring as a result of VNS, no firm conclusions can be drawn based solely on the mean 
HR and BP data presented here. This fact emphasizes the need for additional analytic 
techniques to elucidate underlying physiology, which was a primary motivating factor for 
this thesis research.  
Frequency Domain Parameters – Unresolved Questions 
It is recommended that Appendix A be read before the following sections. As 
discussed there, the use of frequency domain analysis and specifically the use of HF 
power, LF power, and the LF/HF ratio as parameters to gauge autonomic balance is an 
appealing research technique. However, several questions remain regarding the 
application of spectral analysis to this data.  Firstly, physiological correlates of LF power 
remain controversial, and the use of the LF band as a marker of autonomic tone is 
questionable (see Appendix A) [40]. Secondly, if one were to use LF power as a marker 
of autonomic balance, it would seem necessary to witness a “peak” in the LF power 
spectrum range, or at least observe distinct LF oscillations in the HR and BP trace. For 
data here, no peak was found in the LF range, and no consistent “Mayer Waves” were 
seen. It remains unclear whether the observation of an LF peak is necessary to conduct 
   45 
spectral analysis. It may be that in order to observe the LF peak, spectral analysis must be 
conducted under labarotory conditions in which physical activity and breathing are 
controlled. Parati cites this as a necessary condition for short-term spectral analysis but it 
appears many authors do not adhere to this requirement [41]. Lastly, there seems to be 
disagreement on what range constitutes the low frequency band in rats. As seen in Table 
2.1, authors use different values, so it is unclear which range is correct. It would seem 
logical that the band should be based on the data, and centered on the LF peak, but again, 
no LF peak was observed.   
In conclusion, there are too many questions surrounding the use of LF power as 
an analysis tool to warrant its use in this study. In contrast, most authors agree on the 
correlation between high frequency oscillations in HR and level of parasympathetic 
cardiac control; therefore, HF and RMSSD are included in our analysis. HF band ranges 
vary between studies in rats, but are usually between 0.75 – 5 Hz, covering the 
respiratory frequency in rats of about 85 breaths/min (1.4 Hz), which can be elevated in 
cardiovascular disease.  An HF respiratory peak was present for rats in this study (see 
Figure 2.11).  Lastly, VLF power was not used because values for this range are not fully 
established in rats, and ULF power was not measured because the data segments were too 
short to pick up these low frequencies.  
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Effects of Hypertension on Sham Rats 
High Frequency Oscillations in Sham Rats 
RMSSD and HF power for HRV, which aim to quantify oscillations due to 
respiration, decrease significantly in Sham rats from W6 to DBD (P = 0.021, P = 0.032, 
respectively). BRS of “unfiltered” data follows a similar trend in Sham rats (although 
without statistical significance), decreasing from W6 to DBD (Figure 3.9). Lastly, 
RMSSD and HF power of BP increase during the same time period, which may indicate 
that these BP oscillations are not being effectively buffered. In summary, in hypertension, 
respiratory sinus arrhythmia decreased along with BRS at the respiratory frequency, and 
BP oscillations due to respiration increased.  
While many interpret reduced respiratory sinus arrhythmia to reflect a reduced 
parasympathetic cardiac control, a cautious analysis should be used here. Both high 
frequency HRV and high frequency BRS decrease, and there likely is a cause/effect 
relationship between the two variables. Specifically, it appears that HR and BP are 
becoming “uncoupled” due to the progression of HTN at the respiratory rate and this 
uncoupling is caused by a dysfunction in the baroreflex. This dysfunction may occur 
anywhere along the baroreflex arc (Figure 4.1), and does not necessarily indicate that the 
problem lies in the efferent parasympathetic innervation of the heart (vagal tone).  Other 
possibilities could include alterations in the baroreceptors themselves or changes in brain 
processing centers [42].  
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Figure 4.1: Simplified baroreflex arc involved in respiratory sinus arrhythmia. Loss of RSA could 
occur through different means.  
  
Lower Frequency Oscillations and Overall HRV and BPV in Sham Rats 
Decreases in lower frequency oscillations and overall HRV and BPV are seen 
without statistical significance in the Sham group from W6 to DBD in SDNN (P = 0.09) 
and SDANN (P=0.23).  SDNN reflects total HRV while SDANN reflects HRV with 
periods over 5 minutes and corresponds to variability from slower hormonal processes. 
The decreases in these variables likely reflect the negative physiological effects of HTN, 
although it is difficult to trace these parameters back to an exact physiological 
mechanism. A reduction in overall HRV may reflect a decrease in vagal activity leading 
to a prevalence of sympathetic mechanisms and cardiac electrical instability [17].  Henze 
et al showed that SDANN and SDNN were reduced early on in a rat model of heart 
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failure, owing to a progressive loss of baroreflex modulation of sympathetic tone [29]. 
Therefore, the increase in SDNN and SDANN in Sham rats seen here provides tentative 
evidence of the well-known overactive SNS in HTN. More convincingly, it confirms the 
prognostic value associated with these metrics and with overall HRV; qualitatively, the 
reduced HRV in Sham rats is consistent with the survival data trends.  
ASDNN results are less ambivalent with Sham rats decreasing from W6 to DBD 
(P = 0.01). ASDNN essentially removes oscillations with periods longer than 5 minutes. 
As mentioned, oscillations with periods over 5 minutes are not well understood, but are 
likely mediated by longer-term humoral control mechanisms, or by circadian rhythms 
[13].  With these oscillations removed, ASDNN may be more reflective of the faster 
responding systems including any baroreflex-mediated oscillations, and those involving 
autonomic innervation. Decreases in ASDNN may indicate increased sympathetic 
activity over parasympathetic activity. 
VNS Rats: Effects of Stimulation 
High Frequency Oscillations in VNS rats 
No statistical significance was found in parameters that gauge high frequency 
fluctuations due to respiration in VNS rats, making analysis in this section somewhat 
speculative. Qualitatively, it appears that HTN exerts negative physiological effects from 
W6 to W9 in VNS rats. Similar trends to Sham rats are seen: RMSSD and HF power in 
HR decrease, BRS at the respiratory frequency decreases, and RMSSD and HF power in 
BP increase. However, from W9 to DBD, all of these trends reverse. This may indicate 
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that VNS is able to preserve or remedy the coupling between HR and BP at the 
respiratory frequency. Data from a larger number of rats is needed to validate these 
claims.  
Lower Frequency Oscillations and Overall HRV and BPV in VNS Rats 
 The significant decreases in overall HRV that are seen in Sham rats are not 
present in VNS rats. SDNN and SDANN qualitatively appear to increase from W9 to 
DBD. As mentioned, this HRV data is able to corroborate survival data: it appears that 
the higher survival rate in VNS corresponds to increased HRV at lower frequencies as 
depicted by SDNN and SDANN. BPV data in VNS rats is largely inconclusive except for 
ASDNN, which increases from W6 to DBD (P = 0.012). As discussed, ASDNN 
represents oscillations with periods under 5 minutes.  With respect to VNS, the marked 
increase in ASDNN in BPV may be due to a loss of baroreflex control. BRS of filtered 
data shows that baroreflex control at frequencies below respiration is lost in both Sham 
and VNS rats (P = 0.030 and P =0.047 respectively), as discussed in the next section.   
Baroreflex Sensitivity 
The threshold criteria listed in Figure 3.6 (minimum sequence count of 4, 
minimum required change in pressure of 1 mmHg and minimum R2 of 0.9 are in line with 
other published studies that have described or used the sequence method [29], [36], [38], 
[39], [43].  Unfortunately, a limited number of studies exist on the sequence method’s use 
in rats. Henze et al found BRS values of normal Sprague-Dawley rats to fall within the 
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ranges of 1-3 ms/mmHg and that in rats with chronic heart failure BRS significantly 
decreased [29].  Stauss found BRS in rats calculated from the sequence method to lie 
between 0.5 ms/mmHg and 1.5 ms/mmHg [43]. Thus, BRS results on unfiltered data in 
this study are in agreement with other studies conducted on rats. 
We are aware of no other study that uses low pass filtering prior to application of 
the sequence algorithm; however, when considering the goal of the sequence method – to 
quantify changes in PI that result from changes in BP – this technique seems valid. 
Additionally, there have been efforts at quantifying the baroreflex using spectral methods 
that aim to divide coherence in BP and HR into different frequency bands [37], [38]; 
filtering the data prior to the sequence technique can be seen as a time domain correlate 
to these spectral methods. In addition, most of the sequences captured by this technique 
are similar to those pictured in Figure 2.15; visually, it appears the baroreflex is 
operating, providing further justification for the use of filtering in conjunction with the 
sequence method.  
As discussed, BRS results provide evidence that the efficacy of the baroreflex at 
the breathing frequency is reduced from W6 to DBD in Sham rats and not in VNS rats. 
BRS of filtered data reflects BP and HR interactions at frequencies below respiration. For 
both Sham and VNS rats, BRS of filtered data decreases from W6 to DBD (P = 0.030, P 
= 0.047, respectively).  Impaired BRS could be the result of abnormalities seen anywhere 
along the baroreflex arc [44]. Impaired BRS has been associated with HTN, increased 
sympathetic tone, and increased arterial stiffness [6], [45]. One proposed mechanism of 
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reduced BRS in HTN is that a reduced vascular compliance in the baroreceptor areas 
causes reduced afferent firing (stretch of the vessels is limited due to stiffening); The 
brain interprets this reduced afferent firing as lower BP, and therefore stimulates SNS 
action which predominates over PNS activity [6], [7].  Regardless of the exact 
mechanisms of reduced BRS, there is little question regarding its association with HTN. 
Reduced BRS is seen in almost all hypertensive patients, and as HTN progresses, BRS 
decreases [46].   
Limitations 
Decisions we made early on in the project led to some difficulties for later 
analysis. The time used for analysis was chosen at the beginning of the study as 10PM-
2AM. Two problems arise from this choice. First, the use of nighttime data may diminish 
physiological manifestations of VNS [20]. Therefore it is advisable to use daytime data in 
order to better distinguish differences between VNS and Sham.  Second, SDNN, SDANN 
and ASDNN are usually calculated over 24 hours, so the fact that this data was taken 
over shorter time periods may have produced less substantial results. Specifically, if 
SDNN and SDANN were calculated over 24 hours for Sham rats, it is likely that even 
more pronounced differences between W6 and DBD would be observed, since HTN 
tends to diminish HR changes due to circadian rhythm.  
In some rats, atrial fibrillation (AF) was present. This does not lead to problems in 
PI detection, but AF episodes often caused significant decreases in pressure and 
sometimes corresponding increases in HR. These episodes are not “filterable” like other 
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arrhythmias.  It is uncertain what affect these AF episodes had on BPV and HRV results. 
Additionally, VNS caused acute changes in BP and HR under rare circumstances. By 
changing HR and BP, VNS could lead to “artificial” HRV and BPV. These effects are 
likely minimal in our study since acute effects of VNS were only seen in 1 VNS rat.  
Future Work and Recommendations 
A future study should analyze 24-hour variability, since HTN is thought to be 
significantly affected by circadian rhythms. Additionally, shorter data segments should be 
collected and analyzed in the daytime from 10AM-2PM, since VNS may have more 
marked effects when rats are sleeping. If problems surrounding frequency domain 
analysis are sufficiently solved, an analysis of LF power and the LF/HF ratio may be 
undertaken to provide further insight into the autonomic balance in VNS and 
hypertensive rats.  
Additionally, frequency domain methods can be used to validate results obtained 
here using the sequence method. Baroreflex sensitivity algorithms in the frequency 
domain compute a spectral BP to PI transfer function, which can be computed over 
specific frequencies. Therefore, this technique can be used to validate the sequence 
method applied to unfiltered data and filtered data.  
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CHAPTER 5: CONCLUSION 
We set out to explore and identify various metrics that can be extracted from ECG 
and pressure data for use in evaluating physiological effects of HTN, and of VNS-treated 
HTN. HRV, BPV, and BRS emerged as promising parameters that can provide a wealth 
of physiological and pathological information. In order to calculate these parameters, we 
discovered that considerable thought and effort must be placed in the “pre-processing” of 
data; that is, how to acquire a clean data set free from noise and ectopic beats. We 
developed methods to conduct effective pre-processing; first, using ECG and pressure 
data, and then, due to fickle ECG traces, using solely pressure data. We developed a QRS 
detection algorithm using pressure and ECG data that could reliably detect the QRS peak 
during VNS “on” periods. Then, using pressure data alone, we developed a novel 
technique to calculate pulse interval from the derivative of the pressure trace, which 
proved to be more accurate than calculating pulse interval from the pressure trace alone.  
We primarily used time domain parameters in this study to evaluate HRV and 
BPV. We created frequency domain techniques in MATLAB to analyze HRV and BPV, 
but too many questions arose surrounding these parameters to warrant their widespread 
use in this study; in subsequent work, these questions may be answered and frequency 
methods may be more reliably used. In addition, BRS quantification was conducted in the 
time domain using the sequence method.  
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Our results confirm HRV, BPV, and BRS parameters can be used successfully to 
quantify pathophysiology in hypertension and that VNS leads to therapeutic 
physiological effects. We draw several conclusions as to the physiological effects of 
HTN and VNS. First, HTN leads to an uncoupling of BP and HR at the respiratory rate, 
and this uncoupling is prevented in VNS rats. This may indicate that VNS is preserving 
vagal tone, although our study cannot confirm an exact mechanism. Overall and lower 
frequency HRV appears to be partially retained in VNS rats compared with Sham rats. To 
further evaluate the effects of VNS, studies of larger numbers of rats during the sleep 
cycle (day time) should be completed, as well as a 24-hour data analysis to elucidate 
HTN and VNS effects on circadian rhythms.   
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APPENDIX A: PHYSIOLOGICAL CORRELATES OF 
CARDIOVASCULAR OSCILLATIONS 
HR is often thought of as a modulator of BP, through several different control 
mechanisms. If the circuitry of these controls mechanisms malfunctions, an inability of 
the body to respond to perturbations in BP is seen as an increased BPV and a decreased 
HRV. Therefore on simplistic level, decreases in overall HRV over time are seen as 
unhealthy, and increases in overall BPV over time are seen as unhealthy, although an 
examination of variability at certain frequencies can reveal deeper insights into 
physiology.  
 
“High Frequency (HF)” Oscillations: 
It is generally accepted that HF oscillations in both BP and HR occur primarily as 
a result of respiration [17], [18], [47]. These HF oscillations in HR are often referred to as 
respiratory sinus arrhythmia (RSA).  The mechanical hypothesis of RSA states that the 
act of respiration mechanically induces fluctuations in venous return, CO, and thus BP 
[47]–[50]. Proof that BP changes at this frequency are mechanically mediated come from 
experiments that show that when the baroreflex is deactivated, such as in brain-dead 
patients, HF BP oscillations induced by the mechanical ventilator are still present [47].  
In addition, HF BP oscillations remain active in denervated donor hearts [51].  
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These fluctuations in BP are then thought to activate the baroreflex to induce 
corresponding oscillations in HR. Through the baroreceptor reflex, efferent nerves 
responding to respiratory oscillations in BP are able to innervate the heart to produce 
corresponding fluctuations in HR. Efferent innervation of the heart at this high frequency 
occurs almost exclusively through vagal input, since the SNS is not fast enough to 
respond [12], [47]. Therefore metrics that aim to measure the amplitude of HF HR 
oscillations, such as RMSSD, and HF power, are often used as indicators of vagal tone 
[18], [48]. Support for these indicators come from studies in which atropine 
administration (a parasympathetic blocker) abolishes almost all oscillations in HR at the 
respiratory frequency, while HF oscillations of BP remain intact [31], [52]. De Boer et al 
created a beat-to-beat mathematical model of HRV which supports the theory that 
respiratory oscillations in HR are secondary to BP oscillations [50]. Pictorial 
representation of the model is displayed in Figure A1. While a majority of the literature 
investigated in this study supported the use of HRV at respiratory frequencies as 
indicative of “vagal tone,” some authors expressed skepticism [48], [53]. The fact that 
some HR oscillations remain after combined cardiac sympathetic and vagal blockade 
indicates that in addition to the vagally-mediated baroreflex pathway, there are other non-
autonomic HF regulators of HR, such as intra-cardiac reflexes and mechanical stretching 
of the SA node [10], [54]. Additionally, a reduced HRV at the respiratory frequency may 
reflect changes in other variables along the baroreflex arc. For example, “vagal tone” 
may be adequate, but if the afferent nerves or baroreceptors themselves become less 
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responsive, this may lead to a decrease in HF HR oscillations.  In summary, high 
frequency HRV is an adequate measure of vagal cardiac control, but should be analyzed 
with caution, and if possible in the context of other HRV and BPV data. 
 
 
Figure A1: DeBoer’s Model BP Control. Note how RSA is mediated through the “fast” vagal 
efferent nerves. 
 
 “Low Frequency (LF)” Oscillations 
Mechanisms of LF oscillations in HR and BP are less understood and their 
representation of the ANS more controversial. The so-called “Mayer waves”  are seen at 
0.1 Hz in humans and 0.4 Hz in rats [13], [48].  They have been used as a marker of 
sympathetic activity despite an unclear understanding of their underlying physiology. 
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There are two prevailing theories for these LF oscillations: the central oscillator theory 
and the baroreflex feedback loop theory. The central oscillatory theory states that LF 
oscillations are generated by brain stem circuits independent of any sensory input [42], 
[48], [55].  These brain stem circuits generate oscillations in efferent sympathetic nervous 
activity (SNA) which results in a oscillations in vasomotor tone, and therefore BP. 
Corresponding oscillations in HR then appear through the baroreflex and are thought to 
buffer, rather than enhance the BP oscillations.  In contrast, the baroreflex feedback loop 
theory, postulates that LF oscillations in both BP and HR are ultimately due to 
respiration. The baroreceptors sense the respiratory-induced changes in BP; the fast vagal 
response causes RSA, but there is also a slower sympathetic response. This slower 
sympathetic response’s interaction with the faster vagal response initiates changes in HR 
and BP at lower frequencies. There are slight variations of this theory involving various 
resonance feedback loops involved in the baroreflex arc.  
Regardless of the theory, historically, LF oscillations have often been used as a 
marker of sympathetic tone and the LF/HF ratio as a marker of autonomic balance; 
however, many have reported the dubious nature of this index [16], [41], [48]. Instead, 
these fluctuations have been shown to have both sympathetic and parasympathetic 
origins; both parasympathetic blockade with atropine and sympathetic blockade with 
propranolol reduce HR oscillations in the LF band [21], [41].  In summary, the LF band 
in HRV mainly represents fluctuations in sympathetic and vagal input to the heart that 
result from variations in BP, however, non-autonomic influences may also play a role. 
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The LF band in BPV seems to be more accepted as a measure of exclusively sympathetic 
tone, but questions still remain on its use.  
 
“Very Low Frequency (VLF)” Oscillations  
The physiological basis for VLF oscillations is still under investigation, although 
VLF measures have the most significant prognostic value in humans. Decreases in this 
band over time have stronger associations to all-cause mortality than either the LF or HF 
bands [16]. Mechanisms involved in VLF fluctuations are thought to be related to ANS 
interactions with thermoregulation, the RAAS, vasomotor activity and other hormonal 
factors.  Efferent sympathetic activity has been shown to modulate some of these 
oscillations; and increases in VLF power or shifting of their frequency may reflect 
increases in efferent sympathetic activity [16]. However, VLF oscillations in HR are 
abolished by atropine, indicating that the PNS plays a role as well [21]. ACE inhibition 
also reduces VLF power by approximately 20%, indicating that the RAAS system also 
plays a role [21]. In this study, VLF oscillations contribute significantly to the time 
domain metrics SDNN, SDANN, and ASDNN.  
 
“Ultra-Low Frequency ULF” oscillations 
This band represents fluctuations with periods over 5 minutes. Like the VLF 
band, the physiological causes of oscillations in the ULF band is still under investigation. 
The ULF band is able to capture day-night differences, so circadian rhythms play a 
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dominant role, but other slow moving hormonal systems such as the RAAS may also 
contribute [16]. This study is not able to measure the ULF  band accurately since the data 
segments are too short.  
 
Frequency Domain Analysis and Hypertension 
In HTN, an overactive SNS or underactive PNS can manifest in HRV and BPV in 
several ways. Guzzetti et al reported that patients with essential HTN are characterized by 
a greater LF power and a smaller HF power of RR interval compared with normotensives 
[56]. These results were interpreted as symptomatic of reduced vagal tone and increased 
SNS activity. The LF band in BPV is enhanced in hypertensives, which may represent 
enhanced peripheral sympathetic drive [8]. At frequencies below the LF band, HTN is 
reported to cause decreases in HRV and increases BPV; the mechanisms of these changes 
are not as well known, although hormonal systems with overactive sympathetic inputs, 
such as the RAAS, may play significant roles [41].  
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APPENDIX B: INSTRUCTIONS FOR MATLAB 
This thesis is accompanied by MATLAB code. Brief instructions are presented 
here but code is also commented with explanations.  
Place all analysis files and MATLAB functions into same folder. Update 
LoadData.m to reflect ASCII file names. Run LoadData.m. This will create variables 
ECGLoad.m, PressureLoad.m, and tLoad.m and saves them to the workspace. Next, run 
RemoveSaturation.m. This removes all saturated segments from pressure signals (and 
ECG) and creates variables ECGcut, PressureCut, and tCut. This script calculates the 
shortest data segment and normalizes all segments to this length. For data analyzed here, 
minimum length was 168 minutes.  
Next, run CleanAllData.m. This file calculates SBPs and calculates pulse interval 
from the derivative of the pressure trace. It also matches SBP and subsequent PI with a 
delay of 1 (this delay can be adjuted).  It also removes arrhythmic artifacts from SBP and 
PI data by calling the function “InterpolateArrythmias.” This function produces a cell, 
called “CleanDataCell.m,” which contains PI data set and corresponding time, and SBP 
data set and corresponding time.  
Once the variable CleanDataCell.m is acquired with data, “post-processing” 
analysis functions/scripts can operate on the data stored within it. The three main scripts 
for analysis are:  BPVandHRV.m, FrequencyMethods.m, and 
Script_For_Sequence_Method.m.  Use BPVandHRV.m to calculate time domain HRV 
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and BPV parameters: SDNN,  RMMSD, SDANN, ASSDNN. Use FrequencyMethods.m 
to calculate frequency domain parameters: HF, LF, VLF, ULF, and total power. Use 
Script_For_Sequence_Method.m, which calls “SequenceMethodFunction.m” to calculate 
BRS and other parameters associated with the sequence method.  
 
